MELEXIS TECHNOLOGIES SA

MELEXIS TECHNOLOGIES SA has been granted 154 US utility patents between 2015 and 2025, placing MELEXIS TECHNOLOGIES SA at rank #2,529 across all assignees tracked by PlainPatent. This portfolio spans 44 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in G01D (MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OT). As a Foreign Corporation, MELEXIS TECHNOLOGIES SA is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 60.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 137 grants, compared with 17 in the 2015–2019 window — a +706% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. MELEXIS TECHNOLOGIES SA's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 44 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MELEXIS TECHNOLOGIES SA against peers pursuing similar technology classes.